Showing results 1 to 6 of 6
Title | Author(s) | Issue Date | |
---|---|---|---|
2020 | |||
Cost-effectiveness of ceritinib in previously untreated ALK-positive advanced non-small cell lung cancer in Hong Kong Proceeding/Conference:ESMO Asia Congress | 2018 | ||
Cost-effectiveness of pembrolizumab compared to ipilimumab and chemotherapy as a first line treatment for patients with advanced melanoma in Hong Kong Proceeding/Conference:Annals of Oncology | 2016 | ||
2020 | |||
Prevalence and prognostic impact of comorbidities in sarcomas: A population-based study of 3746 patients in Hong Kong Proceeding/Conference:Annals of Oncology | 2019 | ||
Prevalence of chemotherapy use and its impact on overall survival in patients with bone and soft tissue sarcomas: A population-based analysis of 3746 patients Proceeding/Conference:Annals of Oncology | 2019 |